KMB Kimberly-Clark Corporation - Common Stock
NASDAQ · Consumer products · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 4, 2026KMB Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
KMB Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 3 listopada 2014 | 1043-for-1000 | Naprzód |
| 3 kwietnia 1997 | 2-for-1 | Naprzód |
| 3 stycznia 1992 | 2-for-1 | Naprzód |
| 26 maja 1987 | 2-for-1 | Naprzód |
| 25 maja 1984 | 2-for-1 | Naprzód |
O Kimberly-Clark Corporation - Common Stock Przegląd firmy z Wikipedii
Kimberly-Clark Corporation is an American multinational consumer goods and personal care corporation that produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes.
Founded in Neenah, Wisconsin, in 1872 and based in the Las Colinas section of Irving, Texas, since 1985, the company operated its own paper mills around the world for decades, but closed the last of those in 2012. With recent annual revenues topping $18 billion per year, Kimberly-Clark is regularly listed among the Fortune 500. As of March 2020, the company had approximately 40,000 employees.
History
Kimberly, Clark and Co. was founded in 1872 by John A. Kimberly, Havilah Babcock, Charles B. Clark and Franklyn C. Shattuck in Neenah, Wisconsin, with $42,000 (equivalent to US$1,128,750 in 2025) of capital. The group's first business was operating paper mills, which the collective expanded throughout the following decades. In 1888, the fledgling company faced a significant setback when its groundwood "Atlas" paper mill burned. Through an extensive effort by labor and management, within five months the mill was rebuilt and in production at a greater capacity. In that same year the company began rapid expansion, purchasing land in a town then known as The Cedars for a new groundwood pulp plant designed by prominent paper mill architects D. H. & A. B. Tower. In 1889, the town was renamed Kimberly after John A. Kimberly. The company would also contract the firm to expand its vast sulphite pulp complex in Appleton, Wisconsin, which allowed it to become the first firm west of Pennsylvania to adopt this improved manufacturing process. The company developed cellu-cotton in 1914, a cotton substitute used by the U.S. Army as surgical cotton during World War I. Army nurses used cellu-cotton pads as disposable sanitary napkins, and six years later the company introduced Kotex, the first disposable feminine hygiene product. Kleenex, a disposable handkerchief, followed in 1924. Kimberly & Clark joined with The New York Times Company in 1926 to build a newsprint mill in Kapuskasing, Ontario, Canada. Two years later, the company went public as Kimberly-Clark.
The firm expanded internationally during the 1950s, opening plants in Mexico, West Germany and the United Kingdom. It began operations in 17 more foreign locations in the 1960s. The company formed Midwest Express Airlines from its corporate flight department in 1984. Kimberly-Clark's headquarters moved from Neenah, Wisconsin to Irving, Texas the following year, although its products are still produced in Neenah. Alongside Cadbury, Kimberly-Clark withdrew advertising support for Lou Grant in 1982, due to pressure from various conservative caucuses campaigning against star Ed Asner. Under the leadership of Darwin Smith as CEO from 1971 to 1991, the company was transformed from a business paper company to a consumer paper products company.
In 1991, Kimberly-Clark and The New York Times Company sold their jointly owned paper mill in Kapuskasing, Ontario. Kimberly-Clark entered a joint venture with Buenos Aires-based Descartables Argentinos S.A. to produce personal care products in Argentina in 1994 and also bought the feminine hygiene unit of VP-Schickedanz (Germany) for $123 million and a 90% stake in Handan Comfort and Beauty Group (China).
Kimberly-Clark merged with Scott Paper in 1995 for $9.4 billion. In 1997, Kimberly-Clark sold its 50% stake in Canada's Scott Paper to forest products company Kruger Inc. and bought diaper operations in Spain and Portugal and disposable surgical masks maker Tecnol Medical Products. Augmenting its presence in Germany, Switzerland and Austria, in 1999 the company paid $365 million for the tissue business of Swiss-based Attisholz Holding. Expanding its offerings of medical products, the company bought Ballard Medical Products in 1999 for $774 million and examination-glove maker Safeskin in 2000 for about $800 million.
Also in 2000, the company bought virtually all of Taiwan's S-K Corporation; the move made Kimberly-Clark one of the largest manufacturers of packaged goods in Taiwan. The company later purchased Taiwan Scott Paper Corporation for about $40 million and merged the two companies, forming Kimberly-Clark Taiwan. In 2001, Kimberly-Clark bought Italian diaper maker Linostar and announced it was closing four Latin American manufacturing plants.
In 2002, Kimberly-Clark purchased paper-packaging rival Amcor's stake in an Australian joint venture. In 2003, Kimberly-Clark added to its global consumer tissue business by acquiring the Polish tissue maker Klucze.
In early 2004, chairman and chief executive officer Thomas Falk began implementation of a global business plan that the company has detailed in July 2003. The firm combined its North American and European groups for personal care and consumer tissue under North Atlantic groups. In 2019, CEO Thomas Falk resigned his position but continued on as the company's chairman of the board. COO Michael D. Hsu became CEO following Falk's retirement.
As of March 2020, the company had approximately 40,000 employees. In April 2020, the Financial Times reported that panic-buying during the COVID-19 pandemic led to a 13 percent increase in sales of Kimberly-Clark's consumer tissues in the first quarter of 2020 compared with the previous year. In April 2020, Kimberly Clark reported an eight percent decline in organic sales, its worst sales performance in at least a decade, according to the Wall Street Journal.
In 2022, Kimberly-Clark acquired majority stake in Thinx, a period underwear brand. Sales declined significantly by 2022 as customers lost the brand's trust regarding the controversy behind the use of PFAS in its products, ending in a class action settlement in 2023. The company eventually recorded an asset impairment for Thinx and Softex Indonesia of $658 million in 2023.
On May 19, 2025, Kimberly-Clark announced that after 41 years, it would transfer its stock from the New York Stock Exchange to the Nasdaq Global Select Market with the changes taking place on May 30 of that year.
In November 2025, Kimberly-Clark announced it would buy Tylenol producer Kenvue for $48.7 billion. The deal would add the Aveeno, Band-Aid, Benadryl, Benylin, Calpol, Carefree, Clean & Clear, Combantrin, Imodium, Listerine, Motrin, Mylanta, Neutrogena, Nicorette, Johnson's Baby, Sudafed, Visine, and Zyrtec brands to the company's portfolio.
On April 7, 2026, the Kimberly-Clark Distribution Center in Ontario, California was set on fire and destroyed. This was filmed by the arsonist, who stated in the video, "all you had to do was pay us enough to live," and "there goes your inventory."
Ownership and subsidiaries
Kimberly-Clark shares are mainly held by institutional investors (The Vanguard Group, BlackRock, State Street Corporation, and others). Its subsidiaries include Kimberly-Clark Professional.
Midwest Airlines
The origin of Midwest Airlines can be traced back to 1948, when Kimberly-Clark opened its corporate flight department and began providing air transportation for company executives and engineers between the company's headquarters in Neenah and its paper mills.
In 1969, K-C Aviation was born from the company's air operations, and was dedicated to the maintenance of corporate aircraft. In 1982, K-C Aviation initiated shuttle flights for Kimberly-Clark employees between Appleton, Memphis, and Atlanta. With this experience, and considering the Airline Deregulation Act of 1978, Kimberly-Clark and K-C Aviation formed a regularly scheduled passenger airline, Midwest Express Airlines, which was started on June 11, 1984. The name of the airline was shortened to Midwest Airlines in 2003.
K-C Aviation divested itself from the airline in 1996. Two years later, Gulfstream Aerospace purchased K-C Aviation from Kimberly-Clark for $250 million, which included its operations at airports in Dallas, Appleton, and Westfield, Massachusetts.
Major product lines
Major American consumer product lines
Kimberly-Clark produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes.
Diapers and incontinence products
Huggies: diapers for infants and toddlers
Little Swimmers: swim diapers, marketed under the Huggies brand
Huggies Pull-Ups: training pants for toddlers undergoing toilet training, marketed under the Huggies brand
GoodNites (DryNites outside North America): pull-on diapers for children, teens and young adults who experience nocturnal enuresis (bedwetting), spun off from the Pull-Ups brand
Poise: Pads and liners for light to moderate urinary incontinence in adult women
Depend: diapers and briefs for adults
Feminine hygiene
Kotex
Kotex is a feminine hygiene product line that includes pantiliners, pads and tampons.
Tissues and wipes
Cottonelle
Cottonelle is a brand name for bath products. Product forms include premium bath tissue and flushable moist wipe products. In June 2019, the Federal Court of Australia found in favour of Kimberly-Clark Australia in Australian Competition & Consumer Commission's (ACCC) case against them for the claim that Kleenex Cottonelle Flushable Cleansing Cloths were advertised as "flushable" in Australia's sewerage system, in contrast to other similar products which warned consumers against flushing them.
The court said that although they contributed to household sewerage system blockages in an unknown number of instances, even faecal matter and toilet paper contributed to those problems. The ACCC argued unsuccessfully that Kimberly-Clark shouldn't be able to take advantage of the difficulty to isolate individual causes in individual cases, and that it was a significant cause of systematic issues. On October 13, 2020, the Cottonelle brand flushable wipes issued a recall because the products manufactured between February through September 2020 may contain Pluralibacter gergovaie.
Kleenex
Kleenex is a brand name of facial tissue paper. Many versions have been made, including "with lotion, our softest ever!" and "regular". In the 1970s, color psychologist Dr. Cody Sweet represented newly styled Kleenex boxes as a national media spokesperson.
Scott
Scott is a brand name of paper napkins, paper towels and bath tissue/wipes.
Viva
Viva is a brand name of heavy-duty paper towels.
Mexican consumer product lines
Kimberly-Clark de Mexico manufactures and markets disposable diapers, feminine-care products, bathroom and facial tissue, napkins, kitchen towels, hand towels, and other paper-based and personal-care products in Mexico. Its brands include Huggies, KleenBebe, Pull-Ups, Evenflo, Kleenex, Kotex, Depend, Kleenex Cottonelle, Petalo, Suavel, Vogue, Sanitas, Marli, Kimlark, Jabon Escudo Antibacterial, and Jabones Kleenex.
Major professional and global products
KimWipes
KimWipes are a type of cleaning tissue commonly used in laboratories. They are used for wiping surfaces, parts, instruments, and laboratory lenses, and can be used to clean liquids, dust, and small particles. They are designed for delicate tasks and have low-lint properties. KimWipes are also FSC certified.
WypAll
WypAll is a brand of disposable cleaning wipes, towels, and cloths. Its products are used for general-purpose cleaning in industrial, commercial, and automotive environments. WypAll GeneralClean X60 Multi-Task Cleaning Cloths are designed to absorb water and remove grease, soil, sticky substances, and residue. They use HydroKnit technology to provide strength and durability for wet or dry cleaning and are disposable rather than laundered.
DryNites
DryNites is a brand of nighttime underwear for children who wet the bed. In the United States, DryNites products are branded as GoodNites.
Softex
Softex is a brand of feminine-care products in Indonesia.
Leadership
Presidents and chairmen of the company have been:
President
John Alfred Kimberly, 1872–1928
Frank J. Sensenbrenner, 1928–1942
Cola Godden Parker, 1942–1953
John Robbins Kimberly, 1953–1959
William R. Kellett, 1959–1964
John R. Kimberly, 1964–1967
Guy McRae Minard, 1967–1970
Darwin Eatna Smith, 1970–1972
Harry John Sheerin, 1972–1978
Robert C. Ernest, 1978–
Chairman
Frank J. Sensenbrenner, 1942–1945
Cola Godden Parker, 1953–1955
John R. Kimberly, 1955–
Guy McRae Minard, 1970–1972
Darwin Eatna Smith, 1972–
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | KMB | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 16.0średnia z 5 lat ≈21.5 | ≈21.5 | 21.0 | Wartość godziwa | |
| P/S (TTM) | 1.9średnia z 5 lat ≈2.4 | ≈2.4 | 2.0 | Wartość godziwa | |
| P/B (MRQ) | 17.9średnia z 5 lat ≈59.2 | ≈59.2 | 8.4 | Zawyżona wycena | |
| Cena / FCF (TTM) | 17.2średnia z 5 lat ≈21.0 | ≈21.0 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 9.4średnia z 5 lat ≈14.3 | ≈14.3 | 13.6 | Wartość godziwa | |
| Cena / Wartość księgowa materialna (MRQ) | 18.7 | · | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | KMB | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 36.8%średnia z 5 lat ≈33.6% | ≈33.6% | 42.3% | Słaby | |
| Marża Operacyjna (TTM) | 14.3%średnia z 5 lat ≈13.6% | ≈13.6% | 18.1% | Słaby | |
| Marża EBITDA (TTM) | 18.7%średnia z 5 lat ≈17.7% | ≈17.7% | 15.0% | Zgodnie z | |
| Marża przed opodatkowaniem (TTM) | 13.5%średnia z 5 lat ≈12.0% | ≈12.0% | 13.0% | Zgodnie z | |
| Marża Zysku Netto (TTM) | 11.8%średnia z 5 lat ≈10.5% | ≈10.5% | 9.1% | Słaby | |
| ROA (TTM) | 11.1%średnia z 5 lat ≈11.6% | ≈11.6% | 8.5% | Najwyższa półka | |
| ROE (TTM) | 129.4%średnia z 5 lat ≈273.1% | ≈273.1% | 32.7% | Najwyższa półka | |
| ROIC | 110.8%średnia z 5 lat ≈279.1% | ≈279.1% | 17.7% | Najwyższa półka |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | KMB | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 0.9średnia z 5 lat ≈0.8 | ≈0.8 | 1.5 | Niska płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 0.4średnia z 5 lat ≈0.4 | ≈0.4 | 0.6 | Niska płynność | |
| Interest Coverage (Pokrycie odsetek) | 9.2średnia z 5 lat ≈9.7 | ≈9.7 | · | · |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | KMB | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | -2.1%średnia z 5 lat ≈-2.8% | ≈-2.8% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | -6.6%średnia z 5 lat ≈-5.0% | ≈-5.0% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | -3.0% | · | · | · | |
| EPS YoY | -19.6%średnia z 5 lat ≈0.24% | ≈0.24% | · | · | |
| Net Income YoY (Zysk Netto R/R) | -20.6%średnia z 5 lat ≈-0.27% | ≈-0.27% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | 2.0%średnia z 5 lat ≈1.8% | ≈1.8% | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | -2.5% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | 1.5%średnia z 5 lat ≈1.4% | ≈1.4% | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | -3.0% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | KMB | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 1.0średnia z 5 lat ≈1.1 | ≈1.1 | 0.8 | Najwyższa półka | |
| Inventory Turnover (Rotacja zapasów) | 7.2średnia z 5 lat ≈6.6 | ≈6.6 | 4.5 | Najwyższa półka | |
| Receivables Turnover (Rotacja należności) | 9.1średnia z 5 lat ≈9.2 | ≈9.2 | 8.9 | Zgodnie z | |
| Revenue / Employee (Przychody / pracownika) | ≈$456.9K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
| Data ex-dywidendy | Kwota | Waluta | Stopa zwrotu |
|---|---|---|---|
| Wrz 4, 2026 | $1,28 | USD | ≈4.9% |
| Cze 5, 2026 | $1,28 | USD | ≈5.1% |
| Mar 6, 2026 | $1,28 | USD | ≈4.8% |
| Gru 5, 2025 | $1,26 | USD | ≈4.9% |
| Wrz 5, 2025 | $1,26 | USD | ≈3.8% |
| Cze 6, 2025 | $1,26 | USD | ≈3.7% |
| Mar 7, 2025 | $1,26 | USD | ≈3.4% |
| Gru 6, 2024 | $1,22 | USD | ≈3.6% |
| Wrz 6, 2024 | $1,22 | USD | ≈3.3% |
| Cze 7, 2024 | $1,22 | USD | ≈3.6% |
| Mar 7, 2024 | $1,22 | USD | ≈3.8% |
| Gru 7, 2023 | $1,18 | USD | ≈3.9% |
| Wrz 7, 2023 | $1,18 | USD | ≈3.7% |
| Cze 8, 2023 | $1,18 | USD | ≈3.5% |
| Mar 9, 2023 | $1,18 | USD | ≈3.8% |
| Gru 8, 2022 | $1,16 | USD | ≈3.4% |
| Wrz 8, 2022 | $1,16 | USD | ≈3.7% |
| Cze 9, 2022 | $1,16 | USD | ≈3.6% |
| Mar 3, 2022 | $1,16 | USD | ≈3.5% |
| Gru 9, 2021 | $1,14 | USD | ≈3.4% |
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Lip 30, 2026 | $2.12 | $2.03 | 4.2% |
| 31 marca 2026 | $1.97 | $1.91 | 3.1% | |
| 31 grudnia 2025 | $1.86 | $1.83 | 1.7% | |
| 30 września 2025 | $1.82 | $1.77 | 2.6% | |
| 30 czerwca 2025 | $1.63 | $1.69 | -3.6% | |
| 31 marca 2025 | $1.93 | $1.91 | 1.3% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.45B | $16.80B | $17.15B | $20.18B | $19.44B | $19.14B | $18.45B | $18.49B | $18.35B | $18.29B | $18.59B | $19.72B | |
| Cost of Revenue | $10.52B | $10.52B | $10.88B | $13.96B | $13.45B | $12.32B | $12.41B | $12.89B | $11.76B | $11.60B | $11.97B | $13.04B | |
| Gross Profit | $5.92B | $6.29B | $6.27B | $6.22B | $5.99B | $6.82B | $6.04B | $5.60B | $6.59B | $6.69B | $6.62B | $6.68B | |
| R&D Expense | $326M | $328M | $303M | $292M | $269M | $276M | $284M | $317M | $309M | $326M | $324M | $368M | |
| Operating Income | $2.35B | $2.70B | $1.93B | $2.68B | $2.56B | $3.24B | $2.99B | $2.23B | $3.36B | $3.38B | $1.61B | $2.52B | |
| Interest Expense | $256M | $270M | $293M | $282M | $256M | $252M | $261M | $263M | $318M | $319M | $295M | $284M | |
| Interest Income | $24M | $48M | $66M | $14M | $6M | $8M | $11M | $10M | $10M | $11M | $17M | $18M | |
| Other Non-op | $-67M | $-60M | $-95M | $-73M | $-86M | $-70M | $-91M | $-163M | $-59M | $-66M | · | · | |
| Pretax Income | $2.05B | $2.42B | $1.61B | $2.34B | $2.23B | $2.93B | $2.65B | $1.81B | $2.99B | $3.01B | $1.33B | $2.25B | |
| Income Tax | $599M | $442M | $343M | $495M | $479M | $676M | $576M | $471M | $776M | $922M | $418M | $856M | |
| Net Income | $2.02B | $2.54B | $1.76B | $1.93B | $1.81B | $2.35B | $2.16B | $1.41B | $2.28B | $2.17B | $1.01B | $1.53B | |
| EPS (Basic) | $6.09 | $7.58 | $5.22 | $5.73 | $5.38 | $6.90 | $6.28 | $4.05 | $6.44 | $6.03 | $2.78 | $4.07 | |
| EPS (Diluted) | $6.07 | $7.55 | $5.21 | $5.72 | $5.35 | $6.87 | $6.24 | $4.03 | $6.40 | $5.99 | $2.77 | $4.04 | |
| Shares (Basic) | 331,900,000 | 335,600,000 | 337,800,000 | 337,400,000 | 337,300,000 | 340,700,000 | 343,600,000 | 348,000,000 | 353,600,000 | 359,400,000 | 363,800,000 | 374,500,000 | |
| Shares (Diluted) | 333,200,000 | 337,000,000 | 338,800,000 | 338,300,000 | 338,800,000 | 342,500,000 | 345,600,000 | 349,600,000 | 355,900,000 | 361,700,000 | 366,300,000 | 377,400,000 | |
| EBITDA | $3.16B | $3.99B | $3.10B | $3.44B | $3.33B | $4.04B | $3.91B | $3.11B | $4.02B | $4.02B | $1.61B | $2.52B |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $688M | $1.01B | $1.09B | $427M | $270M | $303M | $442M | $539M | $616M | $923M | $619M | $789M | |
| Receivables | $1.89B | $1.73B | $2.13B | $2.28B | $2.21B | $2.23B | $2.26B | $2.16B | $2.31B | $2.18B | $2.28B | $2.22B | |
| Inventory | $1.48B | $1.45B | $1.96B | $2.27B | $2.24B | $1.90B | $1.79B | $1.81B | $1.79B | $1.68B | $1.91B | $1.89B | |
| Prepaid Expense | $304M | $292M | $252M | · | · | · | · | · | · | · | · | · | |
| Other Current Assets | $535M | $694M | $520M | $753M | $849M | $733M | $562M | $525M | $490M | $337M | $617M | $655M | |
| Current Assets | $5.31B | $5.58B | $5.70B | $5.73B | $5.57B | $5.17B | $5.06B | $5.04B | $5.21B | $5.12B | $5.43B | $5.56B | |
| PP&E (Net) | $6.78B | $6.28B | $7.91B | $7.88B | $8.10B | $8.04B | $7.45B | $7.16B | $7.44B | $7.17B | $7.10B | $7.36B | |
| PP&E (Gross) | $16.51B | $15.70B | $19.15B | $18.55B | $18.53B | $18.33B | $17.84B | $17.71B | $17.91B | $16.85B | $16.55B | $16.78B | |
| Accum. Depreciation | $9.73B | $9.42B | $11.24B | $10.66B | $10.43B | $10.29B | $10.39B | $10.55B | $10.48B | $9.69B | $9.44B | $9.42B | |
| Goodwill | $1.84B | $1.80B | $1.89B | $2.07B | $1.84B | $1.90B | $1.47B | $1.47B | $1.58B | $1.48B | $1.45B | $1.63B | |
| Intangibles | $77M | $80M | $197M | $851M | $810M | $832M | $29M | · | · | · | · | $109M | |
| Other Non-current Assets | $1.06B | $984M | $1.14B | $1.19B | $1.24B | $1.28B | $1.01B | $620M | $695M | $581M | $619M | $723M | |
| Total Assets | $17.10B | $16.55B | $17.34B | $17.97B | $17.84B | $17.52B | $15.28B | $14.52B | $15.15B | $14.60B | $14.84B | $15.53B | |
| Accounts Payable | $3.39B | $3.26B | $3.65B | $3.81B | $3.84B | $3.34B | $3.06B | $3.19B | $2.83B | $2.61B | $2.61B | $2.62B | |
| Accrued Liabilities | $1.89B | $2.09B | $2.32B | $2.29B | $2.10B | $2.26B | $1.98B | $1.79B | $1.73B | $1.77B | $1.75B | $1.97B | |
| Current Liabilities | $7.12B | $7.00B | $6.93B | $7.33B | $6.75B | $6.44B | $6.92B | $6.54B | $5.86B | $5.85B | $6.35B | $6.23B | |
| Capital Leases | $258M | $265M | $346M | · | · | · | $274M | · | · | · | · | · | |
| Deferred Tax | $445M | $300M | $374M | $647M | $694M | $723M | $511M | $458M | $395M | $532M | $766M | $587M | |
| Other Non-current Liabilities | $646M | $609M | $860M | $799M | $681M | $718M | $520M | $328M | $299M | $309M | $380M | $319M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | $7.40B | $6.70B | $6.18B | |
| Total Debt | · | · | · | · | · | · | · | · | · | $7.40B | $6.70B | $6.18B | |
| Common Stock | $473M | $473M | $473M | $473M | $473M | $473M | $473M | $473M | $473M | $473M | $473M | $536M | |
| Paid-in Capital | $849M | $862M | $878M | $679M | $605M | $657M | $556M | $548M | $594M | $697M | $609M | $632M | |
| Retained Earnings | $9.61B | $9.26B | $8.37B | $8.20B | $7.86B | $7.57B | $6.69B | $5.95B | $5.77B | $5.83B | $4.99B | $8.47B | |
| Treasury Stock | $5.99B | $5.99B | $5.22B | $5.14B | $5.18B | $4.90B | $4.45B | $3.96B | $3.29B | $3.63B | $2.97B | $5.60B | |
| AOCI | $-3.44B | $-3.77B | $-3.58B | $-3.67B | $-3.24B | $-3.17B | $-3.29B | $-3.30B | $-2.92B | $-3.47B | $-3.28B | $-3.31B | |
| Stockholders' Equity | $1.50B | $840M | $915M | $547M | $514M | $626M | $-33M | $-287M | $882M | $-102M | $-174M | $729M | |
| Liabilities + Equity | $17.10B | $16.55B | $17.34B | $17.97B | $17.84B | $17.52B | $15.28B | $14.52B | $15.15B | $14.60B | $14.84B | $15.53B | |
| Shares Outstanding | 331,900,000 | 331,800,000 | 337,000,000 | 337,500,000 | 336,800,000 | 338,700,000 | 341,400,000 | 345,000,000 | 351,100,000 | 356,600,000 | 360,900,000 | 365,300,000 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $805M | $781M | $753M | $754M | $766M | $796M | $917M | $882M | $724M | $705M | $746M | $862M | |
| Stock-based Comp | $140M | $131M | $169M | $150M | $26M | $147M | $96M | $41M | $76M | $77M | $75M | $52M | |
| Deferred Tax | $241M | $-38M | $-322M | $-57M | $-70M | $45M | $29M | $2M | $-69M | $-15M | $-255M | $63M | |
| Amort. of Intangibles | $2M | $7M | $11M | $15M | $9M | $2M | $3M | · | · | · | · | · | |
| Other Non-cash | $-933M | $-7M | $1.76B | $-65M | $240M | $752M | $-751M | $1.02B | $-228M | $633M | · | · | |
| Operating Cash Flow | $2.78B | $3.23B | $3.54B | $2.73B | $2.73B | $3.73B | $2.74B | $2.97B | $2.93B | $3.23B | $2.31B | $2.85B | |
| CapEx | $1.14B | $721M | $766M | $876M | $1.01B | $1.22B | $1.21B | $877M | $785M | $771M | $1.06B | $1.04B | |
| Investing Cash Flow | $-951M | $-100M | $-418M | $-785M | $-1.06B | $-2.31B | $-1.04B | $-902M | $-851M | $-732M | $-1.05B | · | |
| Debt Issued | $0 | $0 | $363M | $0 | $605M | $1.84B | $706M | $507M | $937M | $1.29B | $1.10B | $1.26B | |
| Net Debt Issued | $-550M | $-554M | $-112M | $-312M | $336M | $991M | $-1M | $100M | $-544M | $695M | $547M | $1.13B | |
| Stock Repurchased | $141M | $1.00B | $225M | $100M | $400M | $700M | $800M | $800M | $911M | $739M | $861M | $1.94B | |
| Net Stock Activity | $-141M | $-1.00B | $-225M | $-100M | $-400M | $-700M | $-800M | $-800M | $-911M | $-739M | $-861M | $-1.94B | |
| Dividends Paid | $1.66B | $1.63B | $1.59B | $1.56B | $1.52B | $1.45B | $1.41B | $1.39B | $1.36B | $1.31B | $1.27B | $1.26B | |
| Financing Cash Flow | $-2.18B | $-3.17B | $-2.37B | $-1.76B | $-1.70B | $-1.57B | $-1.79B | $-2.12B | $-2.42B | $-2.19B | $-1.30B | · | |
| Net Change in Cash | $-320M | $-72M | $666M | $157M | $-33M | $-139M | $-97M | $-77M | $-307M | $304M | $-170M | $-265M | |
| Taxes Paid | $497M | $587M | $648M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.64B | $2.51B | $2.78B | $1.86B | $1.72B | $2.51B | $1.53B | $2.09B | $2.14B | $2.46B | $1.25B | $1.81B | |
| Levered FCF | $1.46B | $2.30B | $2.55B | $1.63B | $1.52B | $2.32B | $1.32B | $1.90B | $1.91B | $2.24B | $1.05B | $1.63B |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 36.0% | 35.8% | 34.4% | 30.8% | 30.8% | 35.6% | 32.7% | 30.3% | 35.9% | 36.5% | 35.6% | 33.9% | |
| Operating Margin | 14.3% | 16.0% | 11.5% | 13.3% | 13.2% | 17.0% | 16.2% | 12.1% | 18.1% | 18.2% | 8.7% | 12.8% | |
| Net Margin | 12.3% | 12.7% | 8.6% | 9.6% | 9.3% | 12.3% | 11.7% | 7.6% | 12.5% | 11.9% | 5.5% | 7.7% | |
| Pretax Margin | 12.5% | 14.6% | 9.9% | 11.6% | 11.5% | 15.3% | 14.4% | 9.8% | 16.4% | 16.5% | 7.2% | 11.4% | |
| EBITDA Margin | 19.2% | 19.9% | 15.2% | 17.0% | 17.1% | 21.1% | 21.2% | 16.8% | 22.0% | 22.1% | 8.7% | 12.8% | |
| ROA | 12.0% | 15.0% | 10.0% | 10.8% | 10.3% | 14.3% | 14.5% | 9.5% | 15.3% | 14.7% | 6.7% | 8.9% | |
| ROE | 172.6% | 290.0% | 241.3% | 364.6% | 297.1% | 391.0% | 7843.6% | -1611.4% | 864.5% | -1569.6% | 365.1% | 54.6% | |
| ROIC | 110.8% | 308.4% | 198.8% | 386.4% | 391.0% | 398.6% | -7093.6% | -574.9% | 388.4% | 31.5% | 17.0% | 22.6% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 | 0.9 | 0.9 | 0.9 | 0.9 | |
| Quick Ratio | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | -72.6 | -38.5 | 8.5 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | -63.1 | -35.1 | 7.7 | |
| Interest Coverage | 9.2 | 11.9 | 8.0 | 9.5 | 10.0 | 12.9 | 11.5 | 8.5 | 10.4 | 10.4 | 5.5 | 8.9 |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 1.2 | 1.2 | 1.1 | 1.1 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.1 | |
| Inventory Turnover | 7.2 | 6.8 | 6.3 | 6.2 | 6.5 | 6.7 | 6.9 | 7.2 | 6.7 | 6.4 | 6.3 | 6.3 | |
| Receivables Turnover | 9.1 | 9.7 | 9.3 | 9.0 | 8.8 | 8.5 | 8.3 | 8.3 | 8.1 | 8.2 | 8.3 | 8.3 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.53 | $2.53 | $2.72 | $1.62 | $1.53 | $1.85 | $-0.10 | $-0.83 | $1.79 | $-0.29 | $-0.48 | $2.00 | |
| Revenue / Share | $49.36 | $59.52 | $60.30 | $59.64 | $57.38 | $55.88 | $53.39 | $52.88 | $51.30 | $50.32 | $50.75 | $52.26 | |
| Cash Flow / Share | $8.33 | $9.60 | $10.45 | $8.08 | $8.06 | $10.89 | $7.92 | $8.50 | $8.23 | $8.94 | $6.30 | $7.54 | |
| Cash / Share | $2.07 | $3.08 | $3.24 | $1.27 | $0.80 | $0.89 | $1.29 | $1.56 | $1.75 | $2.59 | $1.72 | $2.16 | |
| Dividend / Share | $5.04 | $4.88 | $4.72 | $4.64 | $4.56 | $4.28 | $4.12 | · | $3.88 | $3.68 | $3.52 | $3.36 | |
| EPS (TTM) | $6.07 | $7.55 | $5.21 | $5.72 | $5.35 | $6.87 | $6.24 | $4.03 | $6.40 | $5.99 | $2.77 | $4.04 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -2.1% | -2.0% | -15.0% | 3.8% | 1.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -6.6% | -4.7% | -3.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -3.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -19.6% | 44.9% | -8.9% | 6.9% | -22.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 2.0% | 12.2% | -8.8% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -2.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -20.6% | 44.3% | -8.8% | 6.6% | -22.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 1.5% | 11.9% | -9.1% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -3.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 2.7% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $16.45B | $16.80B | $17.15B | $20.18B | $19.44B | $19.14B | $18.45B | $18.49B | $18.35B | $18.29B | $18.59B | $19.72B | |
| Net Income TTM | $2.02B | $2.54B | $1.76B | $1.93B | $1.81B | $2.35B | $2.16B | $1.41B | $2.28B | $2.17B | $1.01B | $1.53B | |
| Market Cap | $33.49B | $43.48B | $40.95B | $45.82B | $48.14B | $45.67B | $46.96B | $39.31B | $42.36B | $40.70B | $45.94B | $42.21B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | $47.17B | $52.03B | $47.60B | |
| P/E | 16.6 | 17.4 | 23.3 | 23.7 | 26.7 | 19.6 | 22.0 | 28.3 | 18.9 | 19.1 | 46.0 | 28.6 | |
| P/S | 2.0 | 2.6 | 2.4 | 2.3 | 2.5 | 2.4 | 2.5 | 2.1 | 2.3 | 2.2 | 2.5 | 2.1 | |
| P/B | 22.3 | 51.8 | 44.8 | 83.8 | 93.6 | 73.0 | -1423.0 | -137.0 | 67.4 | -399.0 | -264.0 | 57.9 | |
| P / Cash Flow | 12.1 | 13.4 | 11.6 | 16.8 | 17.6 | 12.2 | 17.2 | 13.2 | 14.5 | 12.6 | 19.9 | 14.8 | |
| P / FCF | 20.4 | 17.3 | 14.8 | 24.7 | 27.9 | 18.2 | 30.8 | 18.8 | 19.8 | 16.5 | 36.8 | 23.4 | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | 11.7 | 32.3 | 18.9 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | 19.2 | 41.6 | 26.4 | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | 2.6 | 2.8 | 2.4 | |
| Dividend Yield | 5.0% | 3.7% | 3.9% | 3.4% | 3.1% | 3.2% | 3.0% | 3.5% | 3.2% | 3.2% | 2.8% | 3.0% | |
| Earnings Yield | 6.0% | 5.8% | 4.3% | 4.2% | 3.7% | 5.1% | 4.5% | 3.5% | 5.3% | 5.2% | 2.2% | 3.5% | |
| Payout Ratio | 82.1% | 64.0% | 90.0% | 80.6% | 83.6% | 61.7% | 65.3% | 98.3% | 59.7% | 60.5% | 125.6% | 82.3% | |
| Annual Payout | $1.66B | $1.63B | $1.59B | $1.56B | $1.52B | $1.45B | $1.41B | $1.39B | $1.36B | $1.31B | $1.27B | $1.26B |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.19B | $4.16B | $4.08B | $4.15B | $4.16B | $4.05B | $4.10B | $4.14B | $4.23B | $4.33B | $1.69B | $5.13B | $5.13B | $5.20B | $4.96B | $5.05B | |
| Cost of Revenue | $2.59B | $2.63B | $2.05B | $2.66B | $2.71B | $2.54B | $2.06B | $2.58B | $2.64B | $3.24B | $711M | $3.29B | $3.40B | $3.47B | $3.34B | $3.51B | |
| Gross Profit | $1.60B | $1.53B | $1.47B | $1.49B | $1.46B | $1.51B | $1.45B | $1.56B | $1.59B | $1.69B | $974M | $1.84B | $1.73B | $1.73B | $1.63B | $1.54B | |
| Operating Income | $633M | $753M | $369M | $621M | $592M | $631M | $282M | $1.03B | $539M | $853M | $254M | $774M | $113M | $787M | $712M | $655M | |
| Interest Expense | $53M | $58M | $60M | $65M | $67M | $64M | $64M | $67M | $72M | $67M | $70M | $74M | $76M | $73M | $76M | $73M | |
| Interest Income | $4M | $5M | $6M | $6M | $5M | $7M | $11M | $18M | $9M | $10M | $32M | $18M | $9M | $7M | $7M | $4M | |
| Other Non-op | $-12M | $-15M | $-16M | $-16M | $-17M | $-17M | $-15M | $-15M | $-15M | $-15M | $-17M | $-20M | $-42M | $-16M | $-24M | $-18M | |
| Pretax Income | $572M | $685M | $436M | $546M | $513M | $557M | $352M | $962M | $461M | · | · | · | · | · | · | · | |
| Income Tax | $217M | $164M | $70M | $248M | $116M | $131M | $11M | $187M | $60M | $184M | $45M | $157M | $-32M | $173M | $139M | $127M | |
| Net Income | $345M | $665M | $499M | $446M | $509M | $567M | $447M | $907M | $544M | $647M | $509M | $587M | $102M | $566M | $507M | $467M | |
| EPS (Basic) | $1.04 | $2.00 | $1.50 | $1.34 | $1.53 | $1.71 | $1.34 | $2.70 | $1.61 | $1.92 | $1.50 | $1.74 | $0.30 | $1.68 | $1.50 | $1.38 | |
| EPS (Diluted) | $1.04 | $2.00 | $1.50 | $1.34 | $1.53 | $1.70 | $1.34 | $2.69 | $1.61 | $1.91 | $1.51 | $1.73 | $0.30 | $1.67 | $1.50 | $1.38 | |
| Shares (Basic) | 332,400,000 | 331,900,000 | · | 331,800,000 | 332,100,000 | 331,800,000 | · | 335,700,000 | 337,100,000 | 336,900,000 | · | 338,100,000 | 338,000,000 | 337,500,000 | · | 337,600,000 | |
| Shares (Diluted) | 333,300,000 | 333,200,000 | · | 333,100,000 | 333,300,000 | 333,300,000 | · | 337,200,000 | 338,000,000 | 338,300,000 | · | 338,900,000 | 338,900,000 | 338,600,000 | · | 338,300,000 | |
| EBITDA | $633M | $946M | · | $621M | $592M | $987M | · | $1.15B | $655M | $1.04B | · | $774M | $113M | $975M | · | $655M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $956M | $542M | $688M | $617M | $634M | $563M | $1.01B | $1.11B | $1.16B | $853M | · | $814M | $580M | $524M | · | $362M | |
| Receivables | $1.86B | $2.00B | $1.89B | $1.97B | $2.01B | $2.18B | $1.73B | $2.23B | $2.31B | $2.38B | · | $2.30B | $2.36B | $2.43B | · | $2.33B | |
| Inventory | $1.54B | $1.48B | $1.48B | $1.54B | $1.56B | $1.91B | $1.45B | $1.94B | $1.92B | $1.88B | · | $2.02B | $2.13B | $2.22B | · | $2.28B | |
| Prepaid Expense | · | · | $304M | · | · | · | $292M | · | · | · | · | · | · | · | · | · | |
| Other Current Assets | $636M | $547M | $535M | $570M | $572M | $633M | $694M | $570M | $565M | $487M | · | $594M | $677M | $673M | · | $649M | |
| Current Assets | $6.35B | $5.29B | $5.31B | $5.47B | $5.56B | $5.28B | $5.58B | $5.85B | $5.95B | $5.60B | · | $5.73B | $5.74B | $5.85B | · | $5.62B | |
| PP&E (Net) | $6.95B | $6.83B | $6.78B | $6.53B | $6.32B | $7.51B | $6.28B | $7.70B | $7.62B | $7.77B | · | $7.70B | $7.82B | $7.87B | · | $7.74B | |
| PP&E (Gross) | $16.84B | $16.69B | $16.51B | $16.36B | $16.08B | $19.17B | $15.70B | $19.32B | $18.98B | $19.06B | · | $18.65B | $18.72B | $18.70B | · | $18.14B | |
| Accum. Depreciation | $9.89B | $9.86B | $9.73B | $9.83B | $9.76B | $11.66B | $9.42B | $11.62B | $11.36B | $11.29B | · | $10.95B | $10.91B | $10.83B | · | $10.41B | |
| Goodwill | $1.83B | $1.84B | $1.84B | $1.83B | $1.84B | $1.97B | $1.80B | $2.06B | $2.02B | $2.04B | $1.89B | $2.04B | $2.09B | $2.09B | $2.07B | $2.04B | |
| Intangibles | $73M | $76M | $77M | · | · | · | $80M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $1.04B | $1.06B | $1.06B | $996M | $1.00B | $1.11B | $984M | $1.10B | $1.13B | $1.12B | · | $1.16B | $1.23B | $1.22B | · | $1.30B | |
| Total Assets | $18.55B | $17.18B | $17.10B | $16.89B | $16.77B | $16.30B | $16.55B | $17.16B | $17.28B | $17.09B | · | $17.15B | $17.38B | $18.18B | · | $17.84B | |
| Accounts Payable | $3.37B | $3.25B | $3.39B | $3.23B | $3.25B | $3.60B | $3.26B | $3.64B | $3.61B | $3.53B | · | $3.49B | $3.71B | $3.79B | · | $3.66B | |
| Accrued Liabilities | $2.27B | $1.90B | $1.89B | $1.87B | $2.02B | $2.14B | $2.09B | $2.45B | $2.18B | $2.13B | · | $2.26B | $2.30B | $2.38B | · | $2.19B | |
| Current Liabilities | $6.99B | $6.90B | $7.12B | $7.08B | $7.17B | $6.92B | $7.00B | $7.07B | $7.01B | $6.88B | · | $6.83B | $6.60B | $7.09B | · | $7.20B | |
| Capital Leases | · | · | $258M | · | · | · | $265M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $473M | $500M | $445M | $413M | $243M | $319M | $300M | $355M | $380M | $395M | · | $404M | $490M | $612M | · | $636M | |
| Other Non-current Liabilities | $622M | $623M | $646M | $653M | $680M | $683M | $609M | $751M | $784M | $796M | · | $809M | $848M | $810M | · | $695M | |
| Common Stock | $473M | $473M | $473M | $473M | $473M | $473M | $473M | $473M | $473M | $473M | · | $473M | $473M | $473M | $473M | $473M | |
| Paid-in Capital | $788M | $867M | $849M | $829M | $798M | $842M | $862M | $844M | $802M | $877M | · | $761M | $697M | $694M | · | $633M | |
| Retained Earnings | $9.77B | $9.85B | $9.61B | $9.52B | $9.49B | $9.41B | $9.26B | $9.28B | $8.73B | $8.60B | · | $8.22B | $8.04B | $8.37B | · | $8.09B | |
| Treasury Stock | $5.89B | $5.98B | $5.99B | $5.99B | $5.99B | $5.99B | $5.99B | $5.75B | $5.24B | $5.25B | · | $5.10B | $5.07B | $5.15B | · | $5.13B | |
| AOCI | $-3.39B | $-3.41B | $-3.44B | $-3.50B | $-3.51B | $-3.63B | $-3.77B | $-3.56B | $-3.63B | $-3.65B | · | $-3.67B | $-3.64B | $-3.66B | · | $-3.63B | |
| Stockholders' Equity | $1.75B | $1.80B | $1.50B | $1.33B | $1.27B | $1.10B | $840M | $1.28B | $1.14B | $1.04B | · | $680M | $500M | $719M | · | $437M | |
| Liabilities + Equity | $18.55B | $17.18B | $17.10B | $16.89B | $16.77B | $16.30B | $16.55B | $17.16B | $17.28B | $17.09B | · | $17.15B | $17.38B | $18.18B | · | $17.84B | |
| Shares Outstanding | 332,600,000 | 331,900,000 | 331,900,000 | 331,900,000 | 331,900,000 | 331,900,000 | 331,800,000 | 333,500,000 | 337,000,000 | 336,800,000 | 337,000,000 | 338,000,000 | 338,200,000 | 337,400,000 | 337,500,000 | 337,500,000 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $167M | $193M | $189M | $176M | $222M | $218M | $217M | $191M | $188M | $185M | $187M | $189M | $189M | $188M | $186M | $188M | |
| Stock-based Comp | $41M | $23M | $25M | $42M | $41M | $32M | $21M | $39M | $39M | $32M | $38M | $60M | $47M | $24M | $49M | $33M | |
| Deferred Tax | $-119M | $36M | $37M | $234M | $-37M | $7M | $48M | $-7M | $-68M | $-11M | $-25M | $-59M | $-188M | $-50M | $74M | $-96M | |
| Other Non-cash | · | $-288M | · | · | · | $-973M | · | · | · | $-782M | · | · | · | $-200M | · | · | |
| Operating Cash Flow | $908M | $745M | $972M | $708M | $770M | $327M | $817M | $958M | $1.02B | $438M | $1.22B | $927M | $787M | $613M | $991M | $798M | |
| CapEx | $352M | $424M | $397M | $340M | $197M | $204M | $209M | $160M | $158M | $194M | $217M | $160M | $188M | $201M | $197M | $209M | |
| Investing Cash Flow | $-410M | $-355M | $-301M | $-338M | $-193M | $-119M | $-194M | $470M | $-195M | $-181M | $-152M | $-191M | $40M | $-115M | $-268M | $-240M | |
| Debt Issued | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $6M | $0 | $9M | $348M | $0 | $0 | |
| Net Debt Issued | · | $-400M | · | · | · | $-250M | · | · | · | $0 | · | · | · | $348M | · | · | |
| Stock Repurchased | $0 | $0 | $1M | $20M | $59M | $61M | $248M | $596M | $102M | $54M | $130M | $32M | $33M | $30M | $26M | $25M | |
| Net Stock Activity | · | $0 | · | · | · | $-61M | · | · | · | $-54M | · | · | · | $-30M | · | · | |
| Dividends Paid | $425M | $418M | $418M | $418M | $419M | $405M | $408M | $411M | $411M | $398M | $399M | $399M | $399M | $391M | $391M | $392M | |
| Financing Cash Flow | $305M | $-527M | $-608M | $-388M | $-500M | $-683M | $-686M | $-1.48B | $-513M | $-485M | $-754M | $-468M | $-755M | $-397M | $-651M | $-489M | |
| Net Change in Cash | $804M | $-142M | $67M | $-23M | $94M | $-458M | $-90M | $-52M | $310M | $-240M | $279M | $234M | $56M | $97M | $65M | $51M | |
| Free Cash Flow | · | $321M | · | · | · | $123M | · | · | · | $244M | · | · | · | $412M | · | · | |
| Levered FCF | · | $277M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.3% | 36.9% | · | 36.0% | 35.0% | 35.8% | · | 36.0% | 36.0% | 37.1% | · | 35.8% | 33.7% | 33.2% | · | 30.5% | |
| Operating Margin | 15.1% | 18.1% | · | 15.0% | 14.2% | 15.9% | · | 23.3% | 13.0% | 16.6% | · | 15.1% | 2.2% | 15.2% | · | 13.0% | |
| Net Margin | 8.2% | 16.0% | · | 10.8% | 12.2% | 11.7% | · | 18.3% | 10.8% | 12.6% | · | 11.4% | 2.0% | 10.9% | · | 9.2% | |
| Pretax Margin | 13.7% | 16.4% | · | 13.2% | 12.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | 15.1% | 22.7% | · | 15.0% | 14.2% | 20.4% | · | 23.3% | 13.0% | 20.2% | · | 15.1% | 2.2% | 18.8% | · | 13.0% | |
| ROA | 1.9% | 4.0% | · | 2.6% | 3.0% | 3.4% | · | 5.3% | 3.1% | 3.7% | · | 3.4% | 0.57% | 3.1% | · | 2.6% | |
| ROE | 22.8% | 45.9% | · | 34.1% | 42.3% | 52.9% | · | 92.3% | 66.5% | 73.4% | · | 105.1% | 18.7% | 79.5% | · | 102.5% | |
| ROIC | 22.4% | 31.9% | · | 25.4% | 36.0% | · | · | · | · | · | · | · | · | · | · | · |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | 0.9 | 0.8 | · | 0.8 | |
| Quick Ratio | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.4 | 0.4 | · | 0.4 | |
| Interest Coverage | 11.9 | 13.0 | · | 9.6 | 8.8 | 12.0 | · | 17.2 | 9.1 | 12.7 | · | 10.5 | 1.5 | 10.8 | · | 9.0 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 1.7 | 1.6 | · | 1.5 | 1.6 | 1.6 | · | 1.6 | 1.6 | 1.6 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | |
| Receivables Turnover | 2.2 | 2.0 | · | 2.0 | 1.9 | 2.1 | · | 2.2 | 2.2 | 2.1 | · | 2.2 | 2.1 | 2.1 | · | 2.1 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.26 | $5.41 | · | $4.01 | $3.83 | $3.32 | · | $3.85 | $3.37 | $3.10 | · | $2.01 | $1.48 | $2.13 | · | $1.29 | |
| Revenue / Share | $12.57 | $12.49 | · | $12.46 | $12.49 | $14.52 | · | $14.69 | $14.88 | $15.22 | · | $15.14 | $15.15 | $15.34 | · | $14.94 | |
| Cash Flow / Share | · | $2.24 | · | · | · | $0.98 | · | · | · | $1.29 | · | · | · | $1.81 | · | · | |
| Cash / Share | $2.87 | $1.63 | · | $1.86 | $1.91 | $1.70 | · | $3.33 | $3.45 | $2.53 | · | $2.41 | $1.72 | $1.55 | · | $1.07 | |
| Dividend / Share | $1.28 | $1.28 | $1.26 | $1.26 | $1.26 | $1.26 | $1.22 | $1.22 | $1.22 | $1.22 | $1.18 | $1.18 | $1.18 | $1.18 | $1.16 | $1.16 | |
| EPS (TTM) | $5.88 | $6.37 | · | $5.91 | $7.26 | $7.34 | · | $7.72 | $6.76 | $5.45 | · | $5.20 | $4.85 | $5.84 | · | $5.27 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $16.58B | $16.56B | · | $16.47B | $16.46B | $16.53B | · | $14.39B | $15.37B | $16.28B | · | $20.43B | $20.35B | $20.27B | · | $20.18B | |
| Net Income TTM | $1.96B | $2.12B | · | $1.97B | $2.43B | $2.46B | · | $2.61B | $2.29B | $1.84B | · | $1.76B | $1.64B | $1.98B | · | $1.78B | |
| Market Cap | $36.51B | $32.02B | · | $41.27B | $42.79B | $47.20B | · | $47.45B | $46.57B | $43.57B | · | $40.85B | $46.69B | $45.29B | · | $37.98B | |
| P/E | 18.7 | 15.1 | · | 21.0 | 17.8 | 19.4 | · | 18.4 | 20.4 | 23.7 | · | 23.2 | 28.5 | 23.0 | · | 21.4 | |
| P/S | 2.2 | 1.9 | · | 2.5 | 2.6 | 2.9 | · | 3.3 | 3.0 | 2.7 | · | 2.0 | 2.3 | 2.2 | · | 1.9 | |
| P/B | 20.9 | 17.8 | · | 31.0 | 33.7 | 42.9 | · | 36.9 | 41.0 | 41.7 | · | 60.1 | 93.4 | 63.0 | · | 86.9 | |
| P / Cash Flow | · | 43.0 | · | · | · | 144.4 | · | · | · | 99.5 | · | · | · | 73.9 | · | · | |
| Dividend Yield | 4.6% | 5.2% | · | 4.0% | 3.8% | 3.5% | · | 3.4% | 3.5% | 3.7% | · | 3.9% | 3.4% | 3.5% | · | 4.1% | |
| Earnings Yield | 5.4% | 6.6% | · | 4.8% | 5.6% | 5.2% | · | 5.4% | 4.9% | 4.2% | · | 4.3% | 3.5% | 4.3% | · | 4.7% | |
| Payout Ratio | · | 62.9% | · | · | · | 71.4% | · | · | · | 61.5% | · | · | · | 69.1% | · | · | |
| Annual Payout | $1.68B | $1.67B | · | $1.65B | $1.64B | $1.64B | · | $1.62B | $1.61B | $1.59B | · | $1.58B | $1.57B | $1.56B | · | $1.55B |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $16.45B | $16.80B | $17.15B | $20.18B | $19.44B |
| Marża Brutto % | 36.0% | 35.8% | 34.4% | 30.8% | 30.8% |
| Marża Operacyjna % | 14.3% | 16.0% | 11.5% | 13.3% | 13.2% |
| Zysk netto | $2.02B | $2.54B | $1.76B | $1.93B | $1.81B |
| Rozwodniony EPS | $6.07 | $7.55 | $5.21 | $5.72 | $5.35 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 0.7 | 0.8 | 0.8 | 0.8 | 0.8 |
| Wskaźnik Szybkości | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $1.64B | $2.51B | $2.78B | $1.86B | $1.72B |
Właściciele instytucjonalni (13F) 1 853 emitenci · $39.5B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 186 (-28 vs poprzedni kw.) | 111 (-78 vs poprzedni kw.) | 634 (+20 vs poprzedni kw.) | 632 (+39 vs poprzedni kw.) | +29.7M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $4 121 026 993 | 40 846 734 | 10,42% | Akcje |
| BlackRock, Inc. | $3 547 915 016 | 32 321 354 | 8,97% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $2 377 804 260 | 21 661 695 | 6,01% | Akcje |
| STATE STREET CORP | $2 340 807 955 | 21 081 552 | 5,92% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 767 258 471 | 16 099 649 | 4,47% | Akcje |
| FMR LLC | $1 441 676 710 | 13 133 613 | 3,65% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $1 225 542 434 | 11 199 927 | 3,10% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 186 910 957 | 10 812 708 | 3,00% | Akcje |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $894 911 737 | 8 156 490 | 2,26% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $774 386 955 | 7 054 632 | 1,96% | Akcje |
| BANK OF AMERICA CORP /DE/ | $755 397 782 | 6 881 641 | 1,91% | Akcje |
| MORGAN STANLEY | $752 766 612 | 6 857 668 | 1,90% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $712 007 408 | 6 486 357 | 1,80% | Akcje |
| NORGES BANK | $633 769 938 | 5 773 617 | 1,60% | Akcje |
| THORNBURG INVESTMENT MANAGEMENT INC | $632 372 676 | 5 760 888 | 1,60% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $615 581 910 | 5 607 923 | 1,56% | Akcje |
| Sessa Capital IM, L.P. | $572 125 082 | 5 212 035 | 1,45% | Akcje |
| Invesco Ltd. | $542 738 123 | 4 944 321 | 1,37% | Akcje |
| UBS Group AG | $508 555 079 | 4 632 915 | 1,29% | Akcje |
| JPMORGAN CHASE & CO | $458 516 192 | 4 171 741 | 1,16% | Akcje |
| NORTHERN TRUST CORP | $403 599 371 | 3 676 773 | 1,02% | Akcje |
| GOLDMAN SACHS GROUP INC | $387 171 084 | 3 527 112 | 0,98% | Akcje |
| NORDEA INVESTMENT MANAGEMENT AB | $351 863 705 | 3 234 636 | 0,89% | Akcje |
| FEDERATED HERMES, INC. | $296 015 480 | 2 696 688 | 0,75% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $276 573 318 | 2 866 936 | 0,70% | Akcje |
| WELLS FARGO & COMPANY/MN | $266 123 696 | 2 424 375 | 0,67% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $265 100 723 | 2 414 998 | 0,67% | Akcje |
| TWO SIGMA ADVISERS, LP | $246 383 469 | 2 442 100 | 0,62% | Akcje |
| Bank of New York Mellon Corp | $239 611 550 | 2 182 850 | 0,61% | Akcje |
| Legal & General Group Plc | $223 667 999 | 2 037 602 | 0,57% | Akcje |
| ROYAL BANK OF CANADA | $219 363 000 | 1 998 375 | 0,55% | Akcje |
| Nuveen, LLC | $218 373 448 | 1 989 373 | 0,55% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $206 144 767 | 1 877 970 | 0,52% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $190 132 617 | 1 732 100 | 0,48% | Opcja kupna |
| ProShare Advisors LLC | $189 198 364 | 1 723 589 | 0,48% | Akcje |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $188 902 205 | 1 720 891 | 0,48% | Akcje |
| Capital Research Global Investors | $175 673 748 | 1 600 380 | 0,44% | Akcje |
| FRANKLIN RESOURCES INC | $172 944 872 | 1 575 233 | 0,44% | Akcje |
| DEUTSCHE BANK AG\ | $172 048 669 | 1 567 356 | 0,44% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $164 611 092 | 1 499 600 | 0,42% | Akcje |
| HSBC HOLDINGS PLC | $161 188 724 | 1 468 461 | 0,41% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $160 694 771 | 1 463 922 | 0,41% | Akcje |
| Amundi | $149 742 902 | 1 364 152 | 0,38% | Akcje |
| FIRST TRUST ADVISORS LP | $145 368 483 | 1 324 301 | 0,37% | Akcje |
| LPL Financial LLC | $135 068 228 | 1 230 466 | 0,34% | Akcje |
| STIFEL FINANCIAL CORP | $127 518 065 | 1 161 686 | 0,32% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $121 526 367 | 1 107 100 | 0,31% | Opcja sprzedaży |
| AXA Investment Managers S.A. | $119 729 970 | 962 924 | 0,30% | Akcje |
| Squarepoint Ops LLC | $107 951 111 | 983 430 | 0,27% | Akcje |
| CITIGROUP INC | $107 058 480 | 975 298 | 0,27% | Akcje |
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Kimberly-Clark Corporation | 19 października 2009 | · | Pierwotne zgłoszenie | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 82 insiderów · 15 dyrektorzy generalni · 6 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Elane B Stock | Group President, K-C Int'l | 3 maja 2016 A | 20 699 | 0 | 0 | $0 |
| Joanne B Bauer | President, K-C Healthcare | 27 maja 2014 S | 0 | 0 | 0 | $0 |
| Christian A. Brickman | Group President, K-C Int'l. | 17 lutego 2014 F | 25 824 | 0 | 0 | $0 |
| Robert William Black | Group President | 25 kwietnia 2012 M | 20 203 | 0 | 0 | $0 |
| Steven R Kalmanson | Group President | 17 lutego 2008 F | 104 296 | 0 | 0 | $0 |
| William Dudley Lehman | Group President | 8 czerwca 2005 F | 41 538 | 0 | 0 | $0 |
| Robert P Van Der Merwe | Group President | 24 lutego 2005 M | 21 465 | 0 | 0 | $0 |
| Lizanne C Gottung | SVP & Chief HR Officer | 31 października 2016 A | 5 593 | 0 | 0 | $0 |
| Mark A Buthman | Executive Vice President | 19 listopada 2015 S | 99 355 | 0 | 0 | $0 |
| Robert E Abernathy | Executive Vice President | 19 czerwca 2014 A | 79 701 | 0 | 0 | $0 |
| Nancy S. Loewe | Chief Strategy Officer | 30 kwietnia 2014 A | 1 663 | 0 | 0 | $0 |
| Jan Bc Spencer | SVP, Continuous Improvement | 30 kwietnia 2012 M | 37 253 | 0 | 0 | $0 |
| Randy J Vest | Vice President and Controller | 2 lipca 2009 A | 83 007 | 0 | 0 | $0 |
| Ronald D Mccray | SVP, Law & Gov. Affairs | 7 sierpnia 2007 M | 51 944 | 0 | 0 | $0 |
| Kathi P Seifert | Executive Vice President | 1 grudnia 2003 M | · | 0 | 0 | $0 |
| Linda Johnson Rice | Dyrektor | 1 lipca 2015 A | 3 000 | 0 | 0 | $0 |
| John R Alm | Dyrektor | 2 kwietnia 2015 A | 0 | 0 | 0 | $0 |
| Craig G Sullivan | Dyrektor | 3 kwietnia 2012 A | · | 0 | 0 | $0 |
| Dennis R Beresford | Dyrektor | 4 kwietnia 2011 A | 1 500 | 0 | 0 | $0 |
| Pastora San Juan Cafferty | Dyrektor | 9 kwietnia 2007 G | 4 715 | 0 | 0 | $0 |
| Paul J Collins | Dyrektor | 2 kwietnia 2004 A | · | 0 | 0 | $0 |
| Patricia Corsi | · | 31 lipca 2026 M | 1 661 | 0 | 0 | $0 |
| Craig Slavtcheff | · | 31 lipca 2026 M | 6 651 | 0 | 0 | $0 |
| Andrew Scribner | · | 6 maja 2026 S | 0 | 0 | 2 | $-719 290 |
| John Patrick Carmichael | · | 1 maja 2026 A | · | 0 | 0 | $0 |
| Katy Chen | · | 1 maja 2026 A | 8 362 | 0 | 2 | $-288 392 |
| Grant B Mcgee | · | 1 maja 2026 A | 6 144 | 0 | 0 | $0 |
| Francesco Tinto | · | 1 maja 2026 A | · | 0 | 0 | $0 |
| Tamera Fenske | · | 1 maja 2026 A | 29 782 | 0 | 0 | $0 |
| Ehab Abou-Oaf | · | 1 maja 2026 A | 54 593 | 0 | 0 | $0 |
| Stacey J. Panayiotou | · | 1 maja 2026 A | · | 0 | 0 | $0 |
| Russell Torres | · | 1 maja 2026 A | 86 294 | 0 | 0 | $0 |
| Jeffrey P. Melucci | · | 1 maja 2026 A | 64 417 | 0 | 0 | $0 |
| Nelson Urdaneta | · | 1 maja 2026 A | 45 285 | 0 | 0 | $0 |
| Michael D. Hsu | · | 1 maja 2026 A | 332 816 | 0 | 0 | $0 |
| Todd Maclin | · | 9 lutego 2026 P | 10 000 | 2 | 0 | $1 080 275 |
| Deeptha Khanna | · | 2 stycznia 2026 A | · | 0 | 0 | $0 |
| Joseph Romanelli | · | 2 stycznia 2026 A | · | 0 | 0 | $0 |
| Deirdre Mahlan | · | 2 stycznia 2026 A | 25 | 0 | 0 | $0 |
| Christa S Quarles | · | 2 stycznia 2026 A | · | 0 | 0 | $0 |
| John Culver | · | 2 stycznia 2026 A | · | 0 | 0 | $0 |
| Jaime A Ramirez | · | 2 stycznia 2026 A | · | 0 | 0 | $0 |
| Sherilyn S Mccoy | · | 2 stycznia 2026 A | · | 0 | 0 | $0 |
| Sylvia M Mathews | · | 2 stycznia 2026 A | · | 0 | 0 | $0 |
| Mark T Smucker | · | 2 stycznia 2026 A | 827 | 0 | 0 | $0 |
| Mae Jemison | · | 2 stycznia 2026 A | 0 | 0 | 0 | $0 |
| Dunia A Shive | · | 2 stycznia 2026 A | · | 0 | 0 | $0 |
| Zackery A Hicks | · | 4 sierpnia 2025 S | 14 321 | 0 | 0 | $0 |
| Andrew Drexler | · | 1 maja 2025 M | 9 187 | 0 | 0 | $0 |
| Sandra R Karrmann | · | 1 maja 2025 M | 25 493 | 0 | 0 | $0 |
| Gonzalo Uribe | · | 29 lipca 2024 S | 7 377 | 0 | 0 | $0 |
| Doug Cunningham | · | 10 maja 2024 S | 0 | 0 | 0 | $0 |
| Paula Ramos | · | 29 kwietnia 2024 F | 6 033 | 0 | 0 | $0 |
| Robert Edward Long | · | 29 kwietnia 2024 F | 7 536 | 0 | 0 | $0 |
| Alison Lewis | · | 26 kwietnia 2024 M | 18 361 | 0 | 0 | $0 |
| Tristram Wilkinson | · | 26 lutego 2024 F | 27 021 | 0 | 0 | $0 |
| Michael D White | · | 2 stycznia 2024 A | 2 100 | 0 | 0 | $0 |
| DECHERD ROBERT W | · | 3 stycznia 2023 A | 48 444 | 0 | 0 | $0 |
| Shane Azzi | · | 1 maja 2022 M | 1 918 | 0 | 0 | $0 |
| Maria Henry | · | 26 kwietnia 2022 A | 62 169 | 0 | 0 | $0 |
| Ian C Read | · | 3 stycznia 2022 A | 700 | 0 | 0 | $0 |
| Aaron Powell | · | 17 sierpnia 2021 M | 7 774 | 0 | 0 | $0 |
| Kimberly K Underhill | · | 26 lipca 2021 M | 43 024 | 0 | 0 | $0 |
| Abelardo E Bru | · | 4 stycznia 2021 A | · | 0 | 0 | $0 |
| Gustavo Lopez Ghory | · | 31 lipca 2020 A | · | 0 | 0 | $0 |
| Sergio Cruz | · | 29 kwietnia 2020 A | 4 576 | 0 | 0 | $0 |
| Scott J. Boston | · | 29 kwietnia 2020 A | 0 | 0 | 0 | $0 |
| Achal Agarwal | · | 28 lutego 2020 A | 51 254 | 0 | 0 | $0 |
| Nancy J Karch | · | 2 stycznia 2020 A | 0 | 0 | 0 | $0 |
| Marc J Shapiro | · | 2 stycznia 2020 A | 4 000 | 0 | 0 | $0 |
| Thomas J Falk | · | 11 grudnia 2019 G | 562 956 | 0 | 0 | $0 |
| Sandra Macquillan | · | 16 maja 2019 M | 10 429 | 0 | 0 | $0 |
| Anthony J. Palmer | · | 28 lutego 2019 M | 9 159 | 0 | 0 | $0 |
| Fabian T Garcia | · | 2 stycznia 2019 A | · | 0 | 0 | $0 |
| John F Bergstrom | · | 2 stycznia 2019 A | 0 | 0 | 0 | $0 |
| James M Jenness | · | 2 stycznia 2019 A | · | 0 | 0 | $0 |
| Michael T. Azbell | · | 27 listopada 2018 S | 6 432 | 0 | 0 | $0 |
| Larry P. Allgaier | · | 25 kwietnia 2018 M | 963 | 0 | 0 | $0 |
| Paz Gustavo Calvo | · | 3 stycznia 2018 A | 800 | 0 | 0 | $0 |
| Thomas J. Mielke | · | 16 maja 2017 M | 20 494 | 0 | 0 | $0 |
| KIMBERLY CLARK CORP | · | 30 listopada 2004 J | 0 | 0 | 0 | $0 |
| Claudio X Gonzalez | · | 28 listopada 2003 A | 185 706 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 153 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| RSPS · Invesco Exchange-Traded Fund Trust | 3,14% | 135 912 SH | 1 października 2026 | Dziennie |
| RDIV · Invesco Exchange-Traded Fund Trust … | 3,07% | 435 516 SH | 1 października 2026 | Dziennie |
| CVAR · ETF Opportunities Trust | 2,29% | 8 986 NS | 31 lipca 2026 | N-PORT |
| SDG · iShares Trust | 2,12% | 35 961 SH | 11 września 2026 | Dziennie |
| SPHD · Invesco Exchange-Traded Fund Trust … | 2,07% | 666 058 SH | 1 października 2026 | Dziennie |
| PEY · Invesco Exchange-Traded Fund Trust | 2,06% | 223 989 SH | 1 października 2026 | Dziennie |
| PAYR · Federated Hermes ETF Trust | 1,84% | 9 597 NS | 31 lipca 2026 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 1,66% | 196 402 SH | 1 października 2026 | Dziennie |
| IYK · iShares Trust | 1,51% | 211 615 SH | 11 września 2026 | Dziennie |
| KNG · First Trust Exchange-Traded Fund IV | 1,50% | 485 143 NS | 31 lipca 2026 | N-PORT |
| DVY · iShares Trust | 1,47% | 3 525 922 SH | 11 września 2026 | Dziennie |
| FSTA · FIDELITY COVINGTON TRUST | 1,33% | 172 575 NS | 31 lipca 2026 | N-PORT |
| VDC · VANGUARD WORLD FUND | 1,17% | 979 232 SH | 19 sierpnia 2026 | Dziennie |
| FDIV · EA Series Trust | 1,02% | 5 494 NS | 31 lipca 2026 | N-PORT |
| KXI · iShares Trust | 0,88% | 95 544 SH | 11 września 2026 | Dziennie |
| FXG · First Trust Exchange-Traded AlphaDE… | 0,81% | 16 996 NS | 31 lipca 2026 | N-PORT |
| FBCV · FIDELITY COVINGTON TRUST | 0,79% | 12 816 NS | 31 lipca 2026 | N-PORT |
| HDV · iShares Trust | 0,76% | 1 184 971 SH | 11 września 2026 | Dziennie |
| FLRG · FIDELITY COVINGTON TRUST | 0,76% | 20 162 NS | 31 lipca 2026 | N-PORT |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,71% | 11 721 NS | 31 lipca 2026 | N-PORT |
| IIGD · Invesco Exchange-Traded Self-Indexe… | 0,69% | 195 000 | 1 października 2026 | Dziennie |
| FLAG · Global X Funds | 0,64% | 99 NS | 31 lipca 2026 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,63% | 2 132 284 SH | 19 sierpnia 2026 | Dziennie |
| COWZ · Pacer Funds Trust | 0,61% | 1 036 710 NS | 31 lipca 2026 | N-PORT |
| TEXN · iShares Trust | 0,54% | 1 033 SH | 11 września 2026 | Dziennie |
| QDEF · FlexShares Trust | 0,52% | 25 830 NS | 31 lipca 2026 | N-PORT |
| SUSA · iShares Trust | 0,51% | 209 891 SH | 11 września 2026 | Dziennie |
| RCGE · EA Series Trust | 0,50% | 4 598 NS | 31 lipca 2026 | N-PORT |
| IMCV · iShares Trust | 0,46% | 54 246 SH | 11 września 2026 | Dziennie |
| ESMV · iShares Trust | 0,39% | 308 SH | 11 września 2026 | Dziennie |
| EQIN · Columbia ETF Trust I | 0,38% | 10 645 NS | 31 lipca 2026 | N-PORT |
| EVUS · iShares Trust | 0,36% | 14 076 SH | 11 września 2026 | Dziennie |
| FVAL · FIDELITY COVINGTON TRUST | 0,36% | 43 273 NS | 31 lipca 2026 | N-PORT |
| DUHP · Dimensional ETF Trust | 0,35% | 397 517 NS | 31 lipca 2026 | N-PORT |
| FQAL · FIDELITY COVINGTON TRUST | 0,35% | 45 446 NS | 31 lipca 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,35% | 7 194 100 SH | 19 sierpnia 2026 | Dziennie |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,34% | 43 807 NS | 31 lipca 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,33% | 13 882 NS | 31 lipca 2026 | N-PORT |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0,32% | 598 738 SH | 1 października 2026 | Dziennie |
| IWP · iShares Trust | 0,31% | 598 437 SH | 11 września 2026 | Dziennie |
| QLC · FlexShares Trust | 0,26% | 23 744 NS | 31 lipca 2026 | N-PORT |
| FDLO · FIDELITY COVINGTON TRUST | 0,25% | 32 734 NS | 31 lipca 2026 | N-PORT |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0,25% | 186 436 NS | 31 lipca 2026 | N-PORT |
| IWR · iShares Trust | 0,24% | 1 353 668 SH | 11 września 2026 | Dziennie |
| ESGU · iShares Trust | 0,24% | 429 938 SH | 11 września 2026 | Dziennie |
| IMCB · iShares Trust | 0,23% | 38 973 SH | 11 września 2026 | Dziennie |
| DIVB · iShares Trust | 0,23% | 46 937 SH | 11 września 2026 | Dziennie |
| IWS · iShares Trust | 0,22% | 334 146 SH | 11 września 2026 | Dziennie |
| RSP · Invesco Exchange-Traded Fund Trust | 0,21% | 1 981 923 SH | 1 października 2026 | Dziennie |
| PXH · Invesco Exchange-Traded Fund Trust … | 0,20% | 965 221 SH | 1 października 2026 | Dziennie |
| NUMV · Nushares ETF Trust | 0,20% | 8 260 NS | 31 lipca 2026 | N-PORT |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,19% | 272 000 | 1 października 2026 | Dziennie |
| SIZE · iShares Trust | 0,19% | 8 413 SH | 11 września 2026 | Dziennie |
| FFLV · FIDELITY COVINGTON TRUST | 0,19% | 290 NS | 31 lipca 2026 | N-PORT |
| XOEF · iShares Trust | 0,18% | 418 SH | 11 września 2026 | Dziennie |
| EUSA · iShares, Inc. | 0,18% | 35 513 SH | 11 września 2026 | Dziennie |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,18% | 14 588 SH | 1 października 2026 | Dziennie |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,18% | 25 672 NS | 31 lipca 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,17% | 2 647 NS | 31 lipca 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,17% | 3 199 NS | 31 lipca 2026 | N-PORT |
| FFLC · FIDELITY COVINGTON TRUST | 0,15% | 17 018 NS | 31 lipca 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,15% | 4 707 000 | 1 października 2026 | Dziennie |
| VYM · VANGUARD WHITEHALL FUNDS | 0,15% | 1 317 688 SH | 19 sierpnia 2026 | Dziennie |
| ROUS · Lattice Strategies Trust | 0,15% | 9 430 NS | 31 lipca 2026 | N-PORT |
| DFVX · Dimensional ETF Trust | 0,15% | 7 027 NS | 31 lipca 2026 | N-PORT |
| ESG · FlexShares Trust | 0,14% | 1 740 NS | 31 lipca 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0,14% | 3 153 707 SH | 19 sierpnia 2026 | Dziennie |
| HAPI · Harbor ETF Trust | 0,14% | 6 276 NS | 31 lipca 2026 | N-PORT |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,13% | 6 259 000 | 1 października 2026 | Dziennie |
| USXF · iShares Trust | 0,13% | 19 716 SH | 11 września 2026 | Dziennie |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,13% | 76 453 SH | 19 sierpnia 2026 | Dziennie |
| PFM · Invesco Exchange-Traded Fund Trust | 0,12% | 9 454 SH | 1 października 2026 | Dziennie |
| DXUV · Dimensional ETF Trust | 0,11% | 5 770 NS | 31 lipca 2026 | N-PORT |
| IQSU · New York Life Investments ETF Trust | 0,11% | 3 342 NS | 31 lipca 2026 | N-PORT |
| IVE · iShares Trust | 0,11% | 551 033 SH | 11 września 2026 | Dziennie |
| JFLI · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 466 NS | 31 lipca 2026 | N-PORT |
| IUSV · iShares Trust | 0,10% | 289 813 SH | 11 września 2026 | Dziennie |
| FBCG · FIDELITY COVINGTON TRUST | 0,10% | 64 886 NS | 31 lipca 2026 | N-PORT |
| SUSL · iShares Trust | 0,10% | 11 727 SH | 11 września 2026 | Dziennie |
| ILCV · iShares Trust | 0,10% | 12 956 SH | 10 września 2026 | Dziennie |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,09% | 9 223 SH | 1 października 2026 | Dziennie |
| DSI · iShares Trust | 0,09% | 50 924 SH | 11 września 2026 | Dziennie |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,09% | 84 004 SH | 1 października 2026 | Dziennie |
| EGLE · Global X Funds | 0,08% | 17 NS | 31 lipca 2026 | N-PORT |
| PEVC · Pacer Funds Trust | 0,08% | 18 NS | 31 lipca 2026 | N-PORT |
| IOO · iShares Trust | 0,08% | 71 695 SH | 10 września 2026 | Dziennie |
| PRF · Invesco Exchange-Traded Fund Trust | 0,08% | 76 881 SH | 1 października 2026 | Dziennie |
| CATH · Global X Funds | 0,08% | 9 203 NS | 31 lipca 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 2 963 NS | 31 lipca 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,07% | 135 322 SH | 19 sierpnia 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,07% | 302 391 NS | 31 lipca 2026 | N-PORT |
| LGDX · Tidal Trust III | 0,07% | 888 NS | 31 lipca 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,07% | 77 046 NS | 31 lipca 2026 | N-PORT |
| HDUS · Lattice Strategies Trust | 0,07% | 1 227 NS | 31 lipca 2026 | N-PORT |
| CHRI · Global X Funds | 0,07% | 48 NS | 31 lipca 2026 | N-PORT |
| TOPC · iShares Trust | 0,06% | 206 SH | 11 września 2026 | Dziennie |
| USCL · iShares Trust | 0,06% | 17 601 SH | 11 września 2026 | Dziennie |
| DCOR · Dimensional ETF Trust | 0,06% | 18 641 NS | 31 lipca 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,06% | 8 621 410 SH | 19 sierpnia 2026 | Dziennie |
| VV · VANGUARD INDEX FUNDS | 0,06% | 387 707 SH | 19 sierpnia 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,06% | 74 669 SH | 19 sierpnia 2026 | Dziennie |
| TOV · EA Series Trust | 0,06% | 1 457 NS | 31 lipca 2026 | N-PORT |
| IWD · iShares Trust | 0,06% | 497 367 SH | 11 września 2026 | Dziennie |
| XRMI · Global X Funds | 0,06% | 271 NS | 31 lipca 2026 | N-PORT |
| XCLR · Global X Funds | 0,06% | 19 NS | 31 lipca 2026 | N-PORT |
| XYLD · Global X Funds | 0,06% | 17 167 NS | 31 lipca 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,06% | 28 580 NS | 31 lipca 2026 | N-PORT |
| XYLG · Global X Funds | 0,06% | 335 NS | 31 lipca 2026 | N-PORT |
| ACVF · ETF Opportunities Trust | 0,06% | 793 NS | 31 lipca 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,06% | 45 927 NS | 31 lipca 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,06% | 16 801 NS | 31 lipca 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,06% | 5 631 NS | 31 lipca 2026 | N-PORT |
| XVV · iShares Trust | 0,06% | 3 797 SH | 11 września 2026 | Dziennie |
| XTR · Global X Funds | 0,05% | 24 NS | 31 lipca 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,05% | 102 816 NS | 31 lipca 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,05% | 9 054 SH | 1 października 2026 | Dziennie |
| SPUU · Direxion Shares ETF Trust | 0,05% | 1 253 NS | 31 lipca 2026 | N-PORT |
| TILT · FlexShares Trust | 0,05% | 10 270 NS | 31 lipca 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,05% | 7 987 NS | 31 lipca 2026 | N-PORT |
| VOXP · Advisors Series Trust | 0,05% | 27 NS | 31 lipca 2026 | N-PORT |
| ESGG · FlexShares Trust | 0,05% | 513 NS | 31 lipca 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,05% | 1 978 SH | 1 października 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,05% | 10 538 804 SH | 19 sierpnia 2026 | Dziennie |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,05% | 54 444 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,05% | 27 806 SH | 19 sierpnia 2026 | Dziennie |
| IVV · iShares Trust | 0,05% | 4 183 877 SH | 11 września 2026 | Dziennie |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,05% | 57 294 SH | 1 października 2026 | Dziennie |
| ILCB · iShares Trust | 0,05% | 6 441 SH | 11 września 2026 | Dziennie |
| IWB · iShares Trust | 0,05% | 227 976 SH | 11 września 2026 | Dziennie |
| IYY · iShares Trust | 0,05% | 14 141 SH | 11 września 2026 | Dziennie |
| HCMT · Direxion Shares ETF Trust | 0,04% | 2 309 NS | 31 lipca 2026 | N-PORT |
| IWV · iShares Trust | 0,04% | 91 106 SH | 11 września 2026 | Dziennie |
| ITOT · iShares Trust | 0,04% | 423 479 SH | 11 września 2026 | Dziennie |
| PHDG · Invesco Actively Managed Exchange-T… | 0,04% | 264 SH | 1 października 2026 | Dziennie |
| SPXL · Direxion Shares ETF Trust | 0,04% | 25 947 NS | 31 lipca 2026 | N-PORT |
| TOK · iShares Trust | 0,04% | 921 SH | 11 września 2026 | Dziennie |
| URTH · iShares, Inc. | 0,04% | 29 886 SH | 11 września 2026 | Dziennie |
| ACWI · iShares Trust | 0,03% | 106 707 SH | 11 września 2026 | Dziennie |
| IWF · iShares Trust | 0,03% | 398 796 SH | 11 września 2026 | Dziennie |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 282 298 SH | 19 sierpnia 2026 | Dziennie |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,03% | 167 117 SH | 19 sierpnia 2026 | Dziennie |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 3 271 SH | 1 października 2026 | Dziennie |
| FTLS · First Trust Exchange-Traded Fund III | -0,43% | -98 798 NS | 31 lipca 2026 | N-PORT |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 lipca 2026 | Dziennie |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 lipca 2026 | Dziennie |
| VCEB · VANGUARD WORLD FUND | · | · | 30 lipca 2026 | Dziennie |
KMB Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
12-miesięczny cel cenowy
15 analityków · 2026-10-03Średnia cel $116.20 +23,1%
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| KMB | $33.49B | 16.6 | -2.1% | 12.3% | 172.6% | 36.0% |
| PG | $340.77B | 22.2 | 3.3% | 18.4% | 29.8% | · |
| CL | $63.31B | 30.0 | 1.4% | 10.5% | 1603.0% | 60.1% |
| CHD | · | 27.8 | 1.6% | 11.9% | 17.5% | 44.7% |
| CLX | $11.54B | 19.8 | -5.4% | 8.7% | 285.6% | 42.3% |
| REYN | $4.82B | 16.0 | 0.70% | 8.1% | 13.7% | 24.6% |
| WDFC | $2.93B | 32.4 | 5.0% | 14.7% | 35.7% | 55.1% |
| CENT | · | 13.0 | -2.2% | 5.2% | 10.5% | 31.9% |
| SPB | · | 13.6 | -5.2% | · | · | · |
| ENR | $1.70B | 7.5 | 2.3% | 8.1% | 157.3% | 41.8% |
| ODC | $1.12B | 23.1 | 11.0% | 11.1% | 21.8% | 29.5% |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Sygnały transakcyjne Ostatnie sygnały kupna/sprzedaży z ceną wejścia i wskaźnikiem ryzyka/zysku
Obecnie brak otwartego sygnału — żadna karta nie jest wypełniona, i to jest uczciwe.
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.